KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) Income from Continuing Operations (2016 - 2025)

Globus Medical (GMED) has disclosed Income from Continuing Operations for 15 consecutive years, with 140594000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations rose 430.44% year-over-year to 140594000.0, compared with a TTM value of 537868000.0 through Dec 2025, up 422.28%, and an annual FY2025 reading of 537868000.0, up 422.28% over the prior year.
  • Income from Continuing Operations was 140594000.0 for Q4 2025 at Globus Medical, up from 118966000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 202846000.0 in Q2 2025 and bottomed at 197195000.0 in Q4 2022.
  • Average Income from Continuing Operations over 5 years is 42791350.0, with a median of 46270000.0 recorded in 2021.
  • The sharpest move saw Income from Continuing Operations tumbled 1405.41% in 2022, then skyrocketed 5088.79% in 2024.
  • Year by year, Income from Continuing Operations stood at 15106000.0 in 2021, then crashed by 1405.41% to 197195000.0 in 2022, then soared by 107.62% to 15034000.0 in 2023, then surged by 76.3% to 26505000.0 in 2024, then surged by 430.44% to 140594000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for GMED at 140594000.0 in Q4 2025, 118966000.0 in Q3 2025, and 202846000.0 in Q2 2025.